Shineco(US:SISI) Prnewswireยท2025-08-27 10:30Core Viewpoint - Shineco Inc. has entered a strategic cooperation agreement with BICC Pte Ltd to promote the implementation and redemption of "on-chain cell assets," marking a significant advancement in the RWA ecosystem from technical integration to real-world application [1][2]. Group 1: Strategic Collaboration - The partnership aims to establish a framework for standard-setting, compliance coordination, and scenario exploration to transition from technical feasibility to verifiable applicability [2][3]. - Plus Me Limited will provide full-lifecycle digital management for Shineco's compliant mesenchymal stem cells on the Ethereum mainnet, generating digital identities and issuing ERC-1400/ERC-20 standard "Cell Reimbursement Vouchers" [2][3]. - BICC's iPSC stem cell storage services will be integrated into Shineco's blockchain system, allowing users to redeem vouchers in designated BICC scenarios [2][3]. Group 2: Operational Framework - Shineco will focus on cell quality and offline network standardization, while BICC will emphasize user services and scenario integration [3]. - The collaboration will ensure end-to-end compliance for on-chain cell assets, covering storage, circulation, and application [3]. - The partnership aims to build a decentralized biological cell marketing ecosystem, with a vision to integrate standards and scenarios within a compliance framework [3]. Group 3: Company Background - Shineco, Inc. specializes in induced pluripotent stem cell (iPSC) technology platforms and extracellular vesicle-derived products, aiming to improve the quality of life through safe and efficient health products [5]. - BICC Pte Ltd, founded in 2024, focuses on stem cell treatments and artificial intelligence, leveraging proprietary technologies and a strategic presence across Asia [4].